Bent Jakobsen leaves Immunocore

Immunocore has announced that Bent Jakobsen, Chief Scientific Officer, is leaving Immunocore, effective 28 February 2020. During his distinguished career, Bent founded the precursor to Immunocore, Avidex, as a spin-out from the University of Oxford. He then co-founded Immunocore in 2008 and has played an integral role in the development of our company into the world-class biotechnology company it is today. Immunocore thanks Bent for his contribution and wish him well as he takes this next step.